Weight-loss drug cuts heart attack risk regardless of kilograms shed, study finds

Semaglutide study suggests such drugs could have wider benefits, though researchers find shrinking waistlines linked to better heart outcomes

The weight-loss drug semaglutide cuts the risk of heart attack or stroke regardless of how many kilograms people lose, the largest study of its kind has found.

However, shrinking waist size – a sign of less belly fat – was linked to better heart outcomes, according to the research.